147 related articles for article (PubMed ID: 9029102)
1. Polymorphism in the alpha 1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity.
Barber LD; Percival L; Arnett KL; Gumperz JE; Chen L; Parham P
J Immunol; 1997 Feb; 158(4):1660-9. PubMed ID: 9029102
[TBL] [Abstract][Full Text] [Related]
2. Several HLA alleles share overlapping peptide specificities.
Sidney J; del Guercio MF; Southwood S; Engelhard VH; Appella E; Rammensee HG; Falk K; Rötzschke O; Takiguchi M; Kubo RT
J Immunol; 1995 Jan; 154(1):247-59. PubMed ID: 7527812
[TBL] [Abstract][Full Text] [Related]
3. HLA-B15 peptide ligands are preferentially anchored at their C termini.
Prilliman KR; Jackson KW; Lindsey M; Wang J; Crawford D; Hildebrand WH
J Immunol; 1999 Jun; 162(12):7277-84. PubMed ID: 10358176
[TBL] [Abstract][Full Text] [Related]
4. Naturally occurring A pocket polymorphism in HLA-B*2703 increases the dependence on an accessory anchor residue at P1 for optimal binding of nonamer peptides.
Griffin TA; Yuan J; Friede T; Stevanovic S; Ariyoshi K; Rowland-Jones SL; Rammensee HG; Colbert RA
J Immunol; 1997 Nov; 159(10):4887-97. PubMed ID: 9366414
[TBL] [Abstract][Full Text] [Related]
5. Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes.
Barber LD; Gillece-Castro B; Percival L; Li X; Clayberger C; Parham P
Curr Biol; 1995 Feb; 5(2):179-90. PubMed ID: 7743181
[TBL] [Abstract][Full Text] [Related]
6. HLA-Bw22: a family of molecules with identity to HLA-B7 in the alpha 1-helix.
Hildebrand WH; Madrigal JA; Little AM; Parham P
J Immunol; 1992 Feb; 148(4):1155-62. PubMed ID: 1737933
[TBL] [Abstract][Full Text] [Related]
7. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules.
Sidney J; Southwood S; del Guercio MF; Grey HM; Chesnut RW; Kubo RT; Sette A
J Immunol; 1996 Oct; 157(8):3480-90. PubMed ID: 8871647
[TBL] [Abstract][Full Text] [Related]
8. The impact of HLA-B micropolymorphism outside primary peptide anchor pockets on the CTL response to CMV.
Burrows JM; Wynn KK; Tynan FE; Archbold J; Miles JJ; Bell MJ; Brennan RM; Walker S; McCluskey J; Rossjohn J; Khanna R; Burrows SR
Eur J Immunol; 2007 Apr; 37(4):946-53. PubMed ID: 17357107
[TBL] [Abstract][Full Text] [Related]
9. Overlapping peptide-binding specificities of HLA-B27 and B39: evidence for a role of peptide supermotif in the pathogenesis of spondylarthropathies.
Sobao Y; Tsuchiya N; Takiguchi M; Tokunaga K
Arthritis Rheum; 1999 Jan; 42(1):175-81. PubMed ID: 9920028
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of two chemically modified peptide epitopes for the class I MHC protein HLA-B*2705.
Jones MA; Hislop AD; Snaith JS
Org Biomol Chem; 2006 Oct; 4(20):3769-77. PubMed ID: 17024283
[TBL] [Abstract][Full Text] [Related]
11. Unusual uniformity of the N-linked oligosaccharides of HLA-A, -B, and -C glycoproteins.
Barber LD; Patel TP; Percival L; Gumperz JE; Lanier LL; Phillips JH; Bigge JC; Wormwald MR; Parekh RB; Parham P
J Immunol; 1996 May; 156(9):3275-84. PubMed ID: 8617950
[TBL] [Abstract][Full Text] [Related]
12. Serologic cross-reactivities poorly reflect allelic relationships in the HLA-B12 and HLA-B21 groups. Dominant epitopes of the alpha 2 helix.
Hildebrand WH; Madrigal JA; Belich MP; Zemmour J; Ward FE; Williams RC; Parham P
J Immunol; 1992 Dec; 149(11):3563-8. PubMed ID: 1385528
[TBL] [Abstract][Full Text] [Related]
13. Decamer-like conformation of a nona-peptide bound to HLA-B*3501 due to non-standard positioning of the C terminus.
Menssen R; Orth P; Ziegler A; Saenger W
J Mol Biol; 1999 Jan; 285(2):645-53. PubMed ID: 9878435
[TBL] [Abstract][Full Text] [Related]
14. HLA-DP2: self peptide sequences and binding properties.
Chicz RM; Graziano DF; Trucco M; Strominger JL; Gorga JC
J Immunol; 1997 Nov; 159(10):4935-42. PubMed ID: 9366419
[TBL] [Abstract][Full Text] [Related]
15. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions.
Sette A; Sidney J; Oseroff C; del Guercio MF; Southwood S; Arrhenius T; Powell MF; Colón SM; Gaeta FC; Grey HM
J Immunol; 1993 Sep; 151(6):3163-70. PubMed ID: 7690794
[TBL] [Abstract][Full Text] [Related]
16. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.
Lutz CT; Smith KD; Greazel NS; Mace BE; Jensen DA; McCutcheon JA; Goeken NE
J Immunol; 1994 Nov; 153(9):4099-110. PubMed ID: 7523516
[TBL] [Abstract][Full Text] [Related]
17. Two amino acid changes located in the alpha 1 domain specify the novel HLA-B*27:67 allele affecting the peptide-binding-site characteristics.
Becker PS; Richter R; Schulz M; Seifried E; Seidl C
Tissue Antigens; 2011 Jun; 77(6):599-601. PubMed ID: 21443637
[TBL] [Abstract][Full Text] [Related]
18. Differential tapasin dependence of MHC class I molecules correlates with conformational changes upon peptide dissociation: a molecular dynamics simulation study.
Sieker F; Straatsma TP; Springer S; Zacharias M
Mol Immunol; 2008 Aug; 45(14):3714-22. PubMed ID: 18639935
[TBL] [Abstract][Full Text] [Related]
19. Peptide binding specificities of HLA-B*5701 and B*5801.
Zhang Y; Mei H; Wang Q; Xie J; Lv J; Pan X; Tan W
Sci China Life Sci; 2012 Sep; 55(9):818-25. PubMed ID: 23015131
[TBL] [Abstract][Full Text] [Related]
20. B*2707 differs in peptide specificity from B*2705 and B*2704 as much as from HLA-B27 subtypes not associated to spondyloarthritis.
Gómez P; Montserrat V; Marcilla M; Paradela A; de Castro JA
Eur J Immunol; 2006 Jul; 36(7):1867-81. PubMed ID: 16783853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
